Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02189434
Other study ID # ERMC 14-14
Secondary ID
Status Completed
Phase N/A
First received July 10, 2014
Last updated July 10, 2017
Start date June 2014
Est. completion date April 2016

Study information

Verified date July 2017
Source Eastern Regional Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Serum procalcitonin levels will be considerably higher, for a longer period of time, in patients who develop sepsis compared to patients with SIRS or those who have an uncomplicated post-surgical recovery. Monitoring of serum procalcitonin trends will allow for an earlier diagnosis of, and initiation of treatment for, sepsis compared to current standard ICU methods.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date April 2016
Est. primary completion date April 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Female or male person = 18 years of age

- Biopsy proven carcinoma

- Scheduled for cytoreductive surgery, with or without HIPEC

- Eastern Cooperative Oncology Group (ECOG) performance status (PS) = 0, 1, or 2

- Able to give informed consent for protocol participation

Exclusion Criteria:

- Participants are not able to understand or provide written informed consent

- Pre-operative anti-inflammatory medication use within 72 hours of their baseline blood draw

- Pre-operative infection treatment with corticosteroids within 72 hours of their baseline blood draw

- Immunosuppressive illness other than neoplasm

- Pregnant or lactating female

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Serum procalcitonin lab draws
Blood will be collected in a 4mL capacity, green top lithium heparin tube. Samples can be drawn from a port with other labs. The samples will be centrifuged and then the plasma/serum will be removed and placed into a screw-capped round bottom plastic vial. Samples will be stored at -20?C until processing. Serum samples will be batch processed for each participant at the conclusion of their study period. These draws will be conducted for the sole purpose of this study, and whenever possible, they will be performed at the same time as routine blood draws conducted for medical monitoring to reduce the burden to the patients.

Locations

Country Name City State
United States Eastern Regional Medical Center Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Eastern Regional Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary objective of this study is to determine the natural progression of serum procalcitonin in patients recovering from cytoreductive surgery, with or without HIPEC. end of study
Secondary Observe the patient's post-operative course with regards to serum procalcitonin levels and development of sepsis in patients previously treated with cytoreductive surgery with or without HIPEC. end of study
See also
  Status Clinical Trial Phase
Recruiting NCT05063019 - Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer Index N/A
Recruiting NCT05597683 - Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy N/A
Withdrawn NCT04125225 - What Are the Experiences of Patients With Pseudomyxoma Peritonei?
Withdrawn NCT05390021 - PET/MRI in Endometrial Cancer N/A
Not yet recruiting NCT05353582 - Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases Phase 2
Recruiting NCT05939193 - Effect of Urine-guided Hydration on Acute Kidney Injury After CRS-HIPEC N/A
Completed NCT06398678 - Anesthesia Management in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Not yet recruiting NCT05633199 - Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer N/A
Completed NCT03646474 - Single Dose Tranexamic Acid in Reducing Blood Loss During Cytoreductive Surgery and HIPEC N/A
Completed NCT04981639 - TAP and IMS for HIPEC Phase 3
Completed NCT04744688 - Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment
Recruiting NCT05942209 - ECO-LEAK Technique: Early Detection of Colorectal Anastomotic Leakage by Transvaginal Ultrasound